USD/JPY: Early hike risk grows with 160 test – Standard Chartered
Standard Chartered’s Nicholas Chia and Chong Hoon Park note that new Bank of Japan (BoJ) data show underlying inflation near or above target and a positive output gap, while USD/JPY testing 160 raises the risk of earlier rate hikes than their current Q3 baseline. They also highlight that market pricing for roughly two BoJ hikes by December has remained stable.
USD/JPY pressures BoJ policy timing
"USD/JPY testing 160 raises the risk of the BoJ hiking earlier than our Q3 call. But there is still a high hurdle for the BoJ to meet market expectations of two rate hikes in 2026."
"At face value, the new indicators imply the BoJ may be falling behind the curve given above-target inflation, a positive output gap and a still-accommodative policy stance, proxied by a benchmark rate (0.75%) below the neutral rate range."
"This could explain bear steepening in the 2Y/10Y Japanese government bond (JGB) spread since the outbreak of the war to reflect lingering inflation risks from higher fuel costs."
"This is in contrast to 2Y/10Y spreads mostly bear flattening in other developed markets as policy rate hikes get priced back in on the recent oil price shock."
"Market pricing of roughly two BoJ hikes by December has also been remarkably stable in March."
(This article was created with the help of an Artificial Intelligence tool and reviewed by an editor.)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Mexican Peso nears 18.75 as Iran risks and AI selloff hit sentiment
Tech capital pours into Hollywood! Musk reportedly invests $1 billion in Skydance - financial rescue or strategic deployment?
After the news broke, Skydance's share price rose as much as 7.5% intraday before turning negative, at one point falling more than 4%. Skydance's total debt is nearly $8.7 billion, and the $1 billion capital injection is far below previous market expectations, only enough to cover the company’s interest payments for one quarter. The credit market’s stress signals have not been alleviated. Each new “vote of confidence” may be interpreted as the company needing more funding. CDS market pricing indicates that investors expect larger-scale equity financing to follow.
AI funding concerns reignite and Middle East tensions escalate! Nasdaq posts biggest single-day drop since June, international oil prices surge
Most U.S. stocks closed lower on Thursday as massive capital expenditures and financing pressures in the artificial intelligence (AI) sector once again triggered investor concerns, leading to a large-scale sell-off in technology stocks.
Partial clinical trial data leaked! Moderna (MRNA.US) shares plunged as much as 25% as Wall Street says market expectations are too high
Moderna’s stock price plunged as much as 25% on Thursday after some clinical trial data of its personalized cancer vaccine, developed in collaboration with Merck, was leaked prematurely, triggering a sell-off by investors.
Crypto prices
More
